Background. Infection with Neisseria gonorrhoeae (GC) is characterized by robust neutrophil influx that is insufficient to clear the bacteria. Sustained neutrophilic inflammation contributes to serious clinical sequelae that particularly affect women, including pelvic inflammatory disease and infertility.
Gonorrhea is caused by the human-specific pathogen Neisseria gonorrhoeae (GC) and is an important sexually transmitted infection worldwide, with 78 million cases estimated per year [1] . Lack of a protective immune response, emergence of drug-resistant strains, and lack of a vaccine have prompted the classification of GC as an urgent threat [1] . The hallmark of GC infection is influx of polymorphonuclear leukocytes (neutrophils, or PMNs) [2] . GC evades a protective adaptive immune response and instead skews the immune response toward neutrophilic inflammation [3] . While male urethritis commonly presents with symptoms, up to 80% of female cervical infections are asymptomatic [4] . As a result, clinical complications are most common and serious in women. Cervicitis still occurs in women with asymptomatic infection and, despite neutrophil recruitment, GC can evade neutrophil killing and is not cleared [2, 5] . Sustained neutrophil influx that does not clear infection contributes to severe clinical sequelae including pelvic inflammatory disease, tubal scarring, ectopic pregnancy, and infertility. Although gonococcal infection and resulting neutrophilic inflammation cause significant morbidity in women, to date the mechanisms underlying GC-cervical cell interactions that stimulate neutrophil influx are poorly understood.
During GC infection, mucosal epithelial and resident immune cells secrete cytokines including interleukin 8 (CXCL8; IL-8) that recruit neutrophils from the bloodstream into infected tissue [5] . These cytokines may not be sufficient for the terminal step of neutrophil migration across the epithelium into the apical/luminal compartment, termed neutrophil transmigration [6] . Instead, mucosal epithelial cells release additional chemotactic factors that drive transmigration [7, 8] . Recent work has identified an important role for eicosanoids during neutrophil migration to mucosal bacterial pathogens [6, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Eicosanoids are arachidonic acid (AA)-derived bioactive lipids [22] . The rate-limiting step in eicosanoid generation is liberation of AA by phospholipase A 2 (PLA 2 ) [22] . AA can then be oxidized by lipoxygenases (LOXs) or cyclooxygenases (COXs) to generate eicosanoids, including hepoxilins, leukotrienes, and prostaglandins [22] . Of these, hepoxilin A 3 (HXA 3 ) and leukotriene B 4 (LTB 4 ) are particularly potent neutrophil chemoattractants that coordinate neutrophil migration to sites of infection and inflammation [19, 23, 24] . HXA 3 is produced by different 12-lipoxygenase enzymes that are cell-type specific [25] . Neutrophil chemotactic activity of HXA 3 requires its epoxide ring, which is rapidly degraded by an acidic environment and/or soluble epoxide hydrolase (sEH) [26, 27] . LTB 4 is produced by sequential activity of 5-lipoxygenase (5-LOX) and LTA 4 -hydrolase [28] . LTB 4 is primarily produced by myeloid cells and amplifies neutrophil influx in a number of inflammatory disease processes [23, 24] . Recent work revealed an interplay between bacterial promotion of eicosanoid production and eicosanoid regulation of innate immune responses in the context of host-pathogen interactions [21, 23] .
Neutrophilic inflammation is associated with mucosal infection by pathogenic bacteria including Salmonella, Shigella flexneri, enteroaggregative Escherichia coli, Streptococcus pneumoniae, and Pseudomonas aeruginosa, which use HXA 3 and/or LTB 4 to coordinate neutrophil transepithelial migration [8-10, 14-18, 20, 21] . Each of these pathogens stimulates eicosanoid production in a distinct way, suggesting that individual bacteria have evolved unique mechanisms to co-opt eicosanoid-driven neutrophilic inflammation. In contrast, the signals driving neutrophil influx to gonococcal infection are poorly understood. This is particularly problematic in the context of female infection, where unresolved infection and sustained neutrophilic inflammation contribute to severe clinical consequences. In this work we established a 3-component GC-endocervical cell-neutrophil model, and found evidence to support the hypothesis that eicosanoids are required for the coordination of neutrophil transepithelial migration in response to infection.
MATERIALS AND METHODS

Bacterial Strains and Growth Conditions
A piliated, OpaD-expressing derivative of GC strain FA1090 [29] was used for these studies unless otherwise indicated. Growth conditions are described in the Supplementary Methods.
Human Neutrophil Isolation
Venous blood was collected from healthy human donors who provided informed consent. All human subject research was conducted in accordance with a protocol approved by the University of Virginia Institutional Review Board for Health Sciences Research. The neutrophil preparation protocol is detailed in the Supplementary Methods. Replicate experiments used neutrophils from different donors on separate days.
Cell Culture
Human End1/E6E7 (End1) cells (ATCC CRL-2615) were maintained and polarized End1 monolayers established on inverted Corning Transwell inserts as described previously [30] and in the Supplementary Methods.
Microscopy
End1 monolayers were fixed and stained as described in the Supplementary Methods.
Neutrophil Transmigration Assays
End1 monolayers were washed and inverted into a humidified chamber. Monolayers were apically infected with 2.3 × 10 6 GC colony-forming unit (CFU) equivalents (multiplicity of infection [MOI] = 10) for 1 hour (unless otherwise indicated) at 37°C, 5% carbon dioxide (CO 2 ). To assay neutrophil migration across an uninfected End1 monolayer with GC in the apical reservoir, GC was added to the bottom of a tissue culture well for 1 hour, followed by addition of an End1 monolayer on a Transwell insert immediately prior to addition of neutrophils. Neutrophil migration was assayed as previously described [31] , and detailed in the Supplementary Methods. For all transmigration assays, migration was compared to buffer alone as a negative control or an imposed apical gradient of N-formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLP) (1 μM) over 2 hours as positive control for neutrophil migratory capacity. In all experiments, >1 × 10 5 neutrophils underwent transmigration to fMLP.
Enzyme-Linked Immunosorbent Assay
Supernatants from GC-infected End1 monolayers ± neutrophils were collected, passed through a 0.2-μm filter, and stored at −80°C until processed. Enzyme-linked immunosorbent assays (ELISAs) for IL-8 (R&D Systems) and LTB 4 (Cayman Chemical) were performed per the manufacturers' protocols.
Inhibitor and Drug Treatments
End1 monolayers were pretreated with inhibitors or vehicle controls diluted in Hanks' Balanced Salt Solution with calcium and magnesium, 10mM HEPES, and 5mM NaHCO 3 (HBSS + ) and incubated at 37°C, 5% CO 2 for the indicated times. Monolayers were then thoroughly washed in HBSS + before infection. Inhibitor concentrations are provided in the Supplementary Methods and figure legends. The inhibitors used did not affect GC viability or adherence to End1 monolayers, as assayed by CFU enumeration after saponin lysis, serial dilution, and plating on gonococcal base agar (Supplementary Table 1 ). End1 and neutrophil viability, as monitored by Trypan blue (HyClone) exclusion, was >95% after treatment with inhibitor or vehicle. In all cases, inhibitors or vehicle treatment did not affect neutrophils' ability to migrate toward an imposed apical gradient of fMLP.
Short Hairpin RNA Knockdown
A lentiviral delivery system was used for short hairpin RNA (shRNA) knockdown of 12R-LOX, eLOX-3, or 5-LOX in End1 cells using MISSION (Sigma-Aldrich) shRNA clones for GenBank accession numbers NM_001139.2-2340s21c1 (12R-LOX), NM_021628.1-1945s1c1 (eLOX-3), and NM_000698.1-405s1c1 (5-LOX) as detailed in the Supplementary Methods. 
Lipid Extractions
Lipids were isolated from End1 supernatants using solid phase extraction as described [17, 20] and detailed in the Supplementary Methods.
Statistical Analysis
For neutrophil transmigration assays, results are expressed as the mean ± standard error of the mean for ≥3 independent experiments, with 3 transwells per condition. Statistics were calculated using a 2-tailed Student t test, either unpaired for neutrophil migration and qRT-PCR or paired for ELISA and transmigration to lipid-extracted infection supernatants (Excel). For analysis of MOI-dependent neutrophil transmigration, statistics were calculated using a 1-way analysis of variance with Tukey post hoc test (GraphPad Prism). In all cases, a P value <.05 was considered statistically significant compared either to the negative control (buffer alone) or between groups as indicated.
RESULTS
Contact-Dependent GC Infection of Polarized Endocervical Cell
Monolayers Stimulates Neutrophil Migration
To define factors governing neutrophil migration in response to GC infection, we established an in vitro 3-component system to model infection and neutrophil migration at the endocervix ( Figure 1A ). End1 cells maintain stable expression of endocervical epithelial differentiation markers and upregulate inflammatory biomarkers when exposed to GC [32, 33] , providing a physiologically relevant cell line to model human endocervix. End1 monolayers exhibited apicobasal polarity and junctional integrity, as reflected by increased transepithelial electrical resistance (Supplementary Figure 1A) , inhibition of paracellular flux of 10-kDa fluorescein isothiocyanate-dextran in a divalent cation-dependent manner (Supplementary Figure 1B) , and lateral localization of the tight junctional protein ZO-1 (Supplementary Figure 1C) . These findings agree with previous reports using polarized End1 cells [30, 34] . A piliated, OpaDexpressing derivative of FA1090 GC avidly colonized the apical surface of inverted End1 monolayers 1 hour after inoculation (Supplementary Figure 1D ). Primary human neutrophils were then added to the basal aspect of End1 monolayers, and transepithelial migration into the apical reservoir was measured as cell equivalents of neutrophil myeloperoxidase. GC infection elicited neutrophil transepithelial migration over 2 hours that increased with increasing bacterial inoculum ( Figure 1B) . In all experiments, 2 hours of exposure to fMLP was included as a positive control and buffer alone (no apical stimulus) as a negative control ( Figure 1B ). MOI-dependent neutrophil migration to GC was also observed after 4 hours of apical infection at lower inocula (Supplementary Figure 2A) , and migration was similar between infection with an MOI of 10 after 1 hour and an MOI of 3 after 4 hours (Supplementary Figure 2B) . After 1 hour of infection at an MOI of 10, migration that was significantly greater than the negative control was first observed 75 minutes after adding neutrophils and increased at times thereafter ( Figure 1C) , with migration to fMLP measured after 2 hours ( Figure 1C ). The following experiments were performed with 1 hour GC infection at MOI of 10 and 2 hours' neutrophil migration, unless otherwise noted. Neutrophils that had migrated across GC-infected End1 monolayers appeared highly polarized and protrusive by scanning electron microscopy (Supplementary Figure 1E) .
We hypothesized that GC-endocervical cell contact is required to stimulate neutrophil migration. In support of this hypothesis, there was no neutrophil transepithelial migration when GC was in the apical reservoir but not in contact with the End1 monolayers ( Figure 1D ). Under these conditions, GC did not associate with the End1 apical surface, as assessed by CFU enumeration (Supplementary Table 1 ) and confocal microscopy (Supplementary Figure 3) . Also in support of this hypothesis, neutrophils did not migrate across acellular inserts toward equivalent CFU of GC ( Figure 1D ). In both conditions, neutrophils still migrated toward fMLP; migration across the End1 monolayer was greater than that observed across an acellular insert, likely because the presence of the monolayer helped maintain a concentration gradient of fMLP. Type IV pili and opacity-associated (Opa) proteins, major GC adhesins [29] , were dispensable for neutrophil transepithelial migration in this system, when normalized to equivalent adhered CFU (Supplementary Figure 4 ; Supplementary Table 1) . These results show that polarized endocervical cells are necessary and sufficient to coordinate the migration of neutrophils after apical infection with GC, without requiring pili and Opa proteins.
Neutrophil Transepithelial Migration to GC Requires
Neutrophil-Derived Leukotriene B 4 Given that human gonococcal infection is characterized by neutrophil recruitment, we examined the possibility that the eicosanoid neutrophil chemoattractant LTB 4 is involved. LTB 4 accumulated over time in the apical medium of GC-infected End1 monolayers following neutrophil transepithelial migration ( Figure 2A ). LTB 4 concentrations were significantly higher in apical compared to basal medium after 2 hours, suggesting establishment of an apical-to-basolateral gradient of LTB 4 following infection (Figure 2A ). To evaluate if LTB 4 contributed to neutrophil transepithelial migration, LY223982, an antagonist to the high-affinity LTB 4 receptor BLT 1 , was added to the apical medium [20] . LY223982 significantly inhibited neutrophil transepithelial migration following GC infection in a concentration-dependent manner ( Figure 2B ). LTB 4 -BLT 1 interaction increases the liberation of AA to consequently stimulate more LTB 4 production [23, 24] .These results show that LTB 4 is released during neutrophil migration across GC-infected End1 monolayers, and implicate LTB 4 signaling through BLT 1 as a contributor to potent neutrophil recruitment during GC infection.
We next sought to determine the source of LTB 4 released during GC infection. While neutrophils are major producers of LTB 4 , epithelial cells can potentially make this eicosanoid [35, 36] . However, expression of alox5, which encodes 5-LOX, was poorly detected in uninfected and infected End1 cells (Supplementary Table 3 ). Pretreatment of End1 cells with the 5-LOX inhibitors Zileuton or caffeic acid did not affect neutrophil transepithelial migration following GC infection ( Figure 2C ). Furthermore, stable lentiviral-mediated delivery of shRNA targeting alox5 to End1 Figure 1 . Contact-dependent Neisseria gonorrhoeae (GC) infection of polarized endocervical cell monolayers stimulates neutrophil transepithelial migration. Human End1/ E6E7 (End1) monolayers were grown on the underside of collagen-coated Transwell inserts (6.5 mm diameter, 3.0-μm pores). Neutrophil transepithelial migration was quantified by myeloperoxidase (MPO) assay. A, Schematic of in vitro 3-component system depicting apical infection and neutrophil transepithelial migration. Polarized End1 monolayers were inverted in a humidified chamber and apically infected with GC. Following infection, infected monolayers were thoroughly washed in Hanks' balanced salt solution with calcium and magnesium, 10mM HEPES, and 5mM NaHCO 3 (HBSS + ) to remove nonadherent bacteria and reverted into a 24-well tissue culture well containing 1 mL HBSS + . Primary human neutrophils (1 × 10 6 ) were added to the basolateral reservoir and transmigration was allowed to proceed for 2 hours unless otherwise noted. Monolayers were then removed and the number of neutrophils in the apical reservoir quantified by MPO assay. B, Polarized End1 monolayers were infected at various multiplicities of infection (MOI) for 1 hour and then assayed for neutrophil transepithelial migration. C, Polarized End1 monolayers were apically infected with GC at an MOI = 10 for 1 hour, and then neutrophil transmigration was assayed after 60, 75, 90, and 120 minutes. D, End1 monolayers were apically infected with GC at MOI = 10, an equivalent number of GC was added to the apical reservoir without interacting with End1 cells, or an equivalent number of GC was added to the apical reservoir an acellular Transwell insert and incubated for 1 hour before assaying for neutrophil transmigration. B-D, White bars represent neutrophil transepithelial migration to buffer alone with no apical stimulus (-), gray bars represent neutrophil transepithelial migration to an imposed apical gradient of N-formyl-l-methionyl-l-leucyl-l-phenylalanine, and black bars represent neutrophil migration to GC. Results are expressed as a mean ± standard error of the mean for at least 3 independent experiments per condition. Statistics for (B) were calculated using a 1-way analysis of variance with Tukey post hoc test, and statistics for (C) and (D) were calculated using a 2-tailed, unpaired Student t test. *P < .05. Abbreviations: Ap., apical; Ba., basolateral; End1, End1 E6/E7 cells; fMLP, fMLP, N-formyl-l-methionyl-l-leucyl-l-phenylalanine; GC, Neisseria gonorrhoeae; MOI, multiplicity of infection; ns, not significant; PMN, polymorphonuclear cell/neutrophil. cells did not affect neutrophil migration ( Figure 2D ). Additionally, no LTB 4 was detected in the apical compartment of infected End1 monolayers in the absence of neutrophils (Figure 2A ). Together these results indicate that End1 cells do not produce LTB 4 during GC infection. Expression of BLT 1 by End1 cells was also negligible compared to the positive control of differentiated HL60 human promyelocytes, in keeping with reports that BLT 1 is primarily expressed on myeloid cells (Supplementary Table 2 ) [23, 24] .
We then tested the hypothesis that neutrophils were the main source of LTB 4 in this system. In support of this hypothesis, GC-induced transepithelial migration was abrogated in neutrophils that were pretreated with Zileuton ( Figure 3A) . This was not due to general effects on neutrophil health or migratory ability, since Zileuton treatment did not inhibit neutrophil migration toward fMLP. Since we had observed neutrophil migration to GC as early as 75 minutes ( Figure 1C A, Supernatants from apical and basolateral compartments following GC infection and/or neutrophil transepithelial migration were collected at the indicated time points and conditions and passed through a 0.2-μm filter, and LTB 4 was quantified by enzyme-linked immunosorbent assay. B, Polarized human End1/E6E7 (End1) monolayers were infected with GC at a multiplicity of infection (MOI) = 10 for 1 hour. During neutrophil transepithelial migration, LY223982, an antagonist to the high-affinity LTB 4 receptor BLT 1 , was added to the apical reservoir immediately prior to addition of neutrophils at the indicated concentrations (μg/mL). Gray bars represent neutrophil transepithelial migration to an imposed apical gradient of LTB 4 and black bars represent neutrophil migration to GC. C, Polarized End1 monolayers were pretreated with 5-lipoxygenase inhibitor Zileuton (25 μM), caffeic acid (50 μM), or an equivalent concentration of the vehicle control (dimethyl sulfoxide) diluted in Hanks' Balanced Salt Solution with calcium and magnesium, 10mM HEPES, and 5mM NaHCO 3 for 1 hour prior to GC infection, thoroughly washed, and infected at an MOI = 10 and neutrophil transepithelial migration. There was no significant difference in neutrophil migration. D, Neutrophil transepithelial migration was assayed across End1 monolayers infected with GC at an MOI = 10 for 1 hour, with End1 cells either stably transformed with vector short hairpin RNA (shRNA) or shRNA against alox5. For all panels, results are expressed as a mean ± standard error of the mean for at least 3 independent experiments per condition. Statistics were calculated using a 2-tailed, paired (A) or unpaired (B and C) Student t test. *P < .05. Abbreviations: Ap., apical; Ba., basolateral; DMSO, dimethyl sulfoxide; LTB 4 , leukotriene B 4 ; LY, LY223982; PMN, polymorphonuclear cell/neutrophil; shRNA, short hairpin RNA.
investigated whether we could inhibit LTB 4 -mediated amplification of GC-induced neutrophil transepithelial migration over time by targeting BLT 1 . When LY223982 was added to the apical medium at 0, 60, or 75 minutes following basolateral addition of neutrophils, the number of apically migrated neutrophils was significantly reduced compared to the untreated condition ( Figure 3B ). This correlated with significantly less LTB 4 in the apical medium when LY223982 was added at 0 or 75 minutes, compared with no treatment ( Figure 3C ). We conclude that transepithelially migrated neutrophils produce LTB 4 over time to establish a chemotactic gradient for neutrophils.
Gc Infection Stimulates Endocervical Cell Signaling Pathways Leading To
12-Lox Activation And Consequent Neutrophil Transepithelial Migration
The observations above led us to hypothesize that infected endocervical cells produce a non-LTB 4 chemoattractant that coordinates neutrophil transmigration, which is then amplified by neutrophil-derived LTB 4 . In support of this hypothesis, we identified a signaling pathway involving epithelial enzymes protein kinase C (PKC) and PLA 2 during neutrophil migration to GC. Pretreatment of End1 monolayers with the pan-PKC inhibitor chelerythrine chloride or the pan-PLA 2 inhibitor ONO-RS-081 completely inhibited neutrophil migration to GC ( Figure 4A and 4B). Neutrophil migration to GC was sensitive to inhibition of cytosolic PLA 2 α (cPLA 2 α), but not soluble PLA 2 ( Figure 4B ). Inhibition of PLA 2 in End1 cells reduced apical LTB 4 to uninfected, negative control concentrations (Supplementary Figure 5) , further supporting our hypothesis that transmigrated neutrophils are the major source for apical LTB 4 . IL-8 is elevated in acute gonorrhea and is produced by End1 cells infected with GC [32, 37] . In agreement, we found that apically infected End1 monolayers released IL-8, with concentrations significantly higher in the basolateral than apical medium ( Figure 4C ). Addition of a neutralizing antibody against IL-8 to both the apical and basolateral medium had no effect on neutrophil migration to GC, but inhibited migration across uninfected End1 cells to exogenously added apical IL-8 ( Figure 4D ). Therefore IL-8, while produced by GC-infected epithelial cells, is not required for basolateral-to-apical neutrophil migration in this system.
The requirement for cPLA 2 implied the involvement of epithelial-derived AA and its metabolite(s) in neutrophil migration to GC. In particular, AA-derived eicosanoids made by 12-LOX are neutrophil chemoattractants important for neutrophil influx to multiple mucosal bacterial pathogens [19, 20, 26] . Pretreatment of End1 monolayers with the 12-LOX inhibitor cinnamyl-3,4-dihydroxy-α-cyanocinnamate completely inhibited GC-dependent neutrophil transpeithelial migration ( Figure 5A ). AA can also be converted to prostaglandins via COX-2; however, pretreatment of End1 monolayers with the COX-2 inhibitor NS398 had no effect on neutrophil transepithelial migration to GC (Supplementary Figure 6) . We therefore focused on 12-LOX downstream of PKC and PLA 2 in epithelial cells. The 12-LOX activity in humans can be catalyzed by 15-LOX, 12-LOX, and 12R-LOX/eLOX-3, encoded by alox15, alox12, alox12b, and aloxe3, respectively [17, 38, 39] . Of these, only alox12b and aloxe3 were expressed in End1 cells, with expression significantly increasing following GC infection ( Figure 5B ; Supplementary Table 3) . Unlike other 12-LOXs, 12R-LOX is reported to work in concert with eLOX-3 to produce HXA 3 [25, [40] [41] [42] . Stable shRNA knockdown of alox12b or aloxe3 ( Figure 5B ) significantly decreased neutrophil migration to GC ( Figure 5C . Neutrophil transepithelial migration to Neisseria gonorrhoeae (GC) requires an epithelial pathway involving protein kinase C and phospholipase A 2 (PLA 2 ), but not apically directed interleukin 8 (IL-8). For treatment with inhibitors of epithelial cell targets, epithelial cells were pretreated with the inhibitor and then washed thoroughly before infection with GC at a multiplicity of infection (MOI) = 10 and neutrophil transepithelial migration. Polarized human End1/E6E7 (End1) monolayers were pretreated with the pan-protein kinase C inhibitor chelerythrine chloride (CCL) (5 μM) (A), or the pan-PLA 2 inhibitor ONO-RS-082 (5 μM), cytosolic PLA 2 α inhibitor (cPLA 2 inhib) (6 μM), or soluble PLA 2 inhibitor 2,4ʹ-dibromoacetophenone (sPLA 2 inhib) (7 μM) (B). C, Supernatants from apical and basolateral compartments following a 3-hour GC infection or mock infection were collected and passed through a 0.2-μm filter, and IL-8 was quantified by enzyme-linked immunosorbent assay. D, Polarized End1 monolayers were infected with GC at an MOI = 10 for 1 hour. During neutrophil transepithelial migration, an IL-8 blocking antibody (20 μg/mL), was added to the apical and basolateral reservoirs immediately prior to addition of neutrophils. Gray bars represent neutrophil transepithelial migration to an imposed apical gradient of IL-8, and black bars represent neutrophil migration to GC. Results are expressed as mean ± standard error of the mean for at least 3 independent experiments per condition. Statistics were calculated using a 2-tailed, unpaired (A, B, and D) or paired (C) Student t test. *P < .05. Abbreviations: Ap., apical; Ba., basolateral; CCL, chelerythrine chloride; cPLA 2 , cytosolic phospholipase A 2 ; DMSO, dimethyl sulfoxide; GC, Neisseria gonorrhoeae; IL-8, interleukin 8; inhib, inhibitor; ns, not significant; NT, no treatment; PMN, polymorphonuclear cell/neutrophil; sPLA 2 , soluble phospholipase A 2 .
(data not shown). These results implicate 12R-LOX and eLOX-3 in coordinating the endocervical response to GC, resulting in neutrophil transepithelial migration.
Three lines of evidence suggested HXA 3 was the 12-LOX product required for endocervical cells to support neutrophil migration. First, apical addition of recombinant sEH, which hydrolyzes the epoxide ring of HXA 3 required for neutrophil chemoattraction to yield the inert trioxilin A 3 [26, 27, 43, 44] , significantly inhibited neutrophil migration to GC ( Figure 5D ). sEH addition did not affect neutrophil migration to an imposed apical gradient of LTB 4 ( Figure 5D ), which does not contain an epoxide ring and is thus insensitive to sEH. Second, HXA 3 is secreted apically by MRP2 channels in the context of other mucosal bacterial infections [12] . Inhibition of the MRP2 efflux pump on End1 cells with MK571 significantly inhibited neutrophil migration to GC ( Figure 5D ). Third, lipid-extracted supernatants from infected End1 monolayers stimulated 2-to 5-fold more neutrophil migration across an acellular insert compared to mock-infected supernatants, a statistically significant increase (Supplementary Figure 7) . HXA 3 is known to partition into the lipid fraction of infection supernatants [17, 20] . Taken together, we conclude that endocervical cells infected with GC stimulate 12R-LOX and eLOX-3 lipoxygenase activity to produce an epoxide-containing eicosanoid, likely HXA 3 , which is essential for neutrophil transepithelial migration.
DISCUSSION
Neisseria gonorrhoeae infection leads to sustained neutrophil influx, but the mechanisms underlying recruitment of neutrophils across the epithelium in the context of GC infection were not previously understood. Our in vitro system demonstrates that GC-endocervical cell contact stimulates eicosanoid-driven neutrophil migration ( Figure 6 ). Following GC infection, endocervical cells produced an apically directed 12-LOX-derived neutrophil chemoattractant (HXA 3 ) that required efflux through MRP2 and was sensitive to sEH. This pathway was dependent on epithelial PKC and cPLA 2 to produce the 12-LOX substrate AA. Transmigrated neutrophils produced the 5-lipoxygenase product LTB 4 , which amplified the apical-to-basolateral neutrophil chemotactic gradient. To our knowledge, this is the first time eicosanoids have been implicated in neutrophil influx to GC. The LTB 4 -BLT 1 axis is important for directing neutrophil chemotaxis to sites of inflammation [24] . Our results reveal a role for LTB 4 in neutrophil influx to GC. In vivo, multiple additional cell types and factors likely influence the inflammatory milieu during GC infection. For example, GC skews the immune response away from a protective adaptive immune response and toward a Th17-driven neutrophilic response during human infection [3] . Interestingly, LTB 4 has recently been shown to induce Th17 cell migration to a greater extent than Th1 or Th2 cell migration [45] . Neutrophil migration and LTB 4 signaling activate neutrophils to combat invading pathogens [23, 46] . Neutrophils recruited to GC infection appeared protrusive, though their activation status remains to be determined. However, given that GC can evade neutrophil killing, neutrophil activation may not control infection, and instead contributes to host cell damage.
Our results indicate a role for epithelial 12R-LOX and eLOX-3 during neutrophil migration to GC. This was surprising, as other bacterial pathogens studied to date stimulate 15-LOX to produce HXA 3 [11, 15] . 12R-LOX is primarily expressed in skin and is unique in that it requires downstream activity of eLOX-3 to generate HXA 3 [25, [40] [41] [42] . The best described function of 12R-LOX and eLOX-3 is to prevent cellular water loss, with mutations in both linked to dry skin disorders [25, 41, 42] . Interestingly, the first reports of 12R-LOX in the context of disease describe accumulation of its product 12R-HETE in psoriatic scales [47] , suggesting that 12R-LOX plays a role during certain inflammatory states. eLOX3 is described as a hepoxilin synthase, and our combined evidence with sEH, the MRP2 efflux pump that exports HXA 3 , and neutrophil chemotactic activity in lipid-enriched fractions from infected End1 supernatants all suggest that HXA 3 coordinates this event. HXA 3 is a highly potent yet labile chemoattractant, which has complicated confirmation of this eicosanoid in this in vitro system.
Many laboratories have demonstrated that pathogens stimulate eicosanoid signaling by affecting AA production [6, 8, 9, 11, [18] [19] [20] . In agreement, we found that endocervical PKC and PLA 2 are required for neutrophil migration to GC. However, GC does not possess the secreted or surface factors employed by these mucosal pathogens to stimulate eicosanoid production [10, 21, 48] . Two major GC adherence factors, Opa proteins and type IV pili, were not required for neutrophil migration. The GC factors that stimulate eicosanoid production will be an important topic for future investigation.
Broadly, our findings highlight the importance of studying context-specific bacterial-epithelial interactions that engage eicosanoid-producing pathways, to identify novel therapeutic targets for infections in which disease is exacerbated by neutrophilic inflammation. Specifically for gonorrhea, sustained neutrophil influx that does not resolve GC infection contributes to host cell damage. With increased failures of antibiotic treatment, we anticipate increased likelihood for inflammatory damage especially in women, leading to pelvic inflammatory disease, ectopic pregnancy, and infertility. Our work suggests targeting this eicosanoid pathway at the cervix would be an attractive adjunctive strategy to mitigate clinical sequelae in infected women. As precedence, immunosuppressive therapy is added to treatment regimens for bacterial meningitis and pneumocystis pneumonia in patients with human immunodeficiency virus [49, 50] . There is also precedence for targeting lipoxygenase pathways in inflammation, with US Food and Drug Administration-approved therapeutics for asthma including Zileuton and the leukotriene receptor antagonist Montelukast. This study reveals novel lines of inquiry into gonorrheal disease pathogenesis to ameliorate the negative, lifelong consequences of gonorrhea in women.
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